Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Pharma Technology Focus: the dengue dilemma
  2. ICER finds lack of evidence to support blockbuster drug price hikes
  3. Prescription dread: measuring psychiatric drugs against the alternatives
  4. Real world data: how can it improve clinical trial outcomes?
  5. US opioid crisis: charting Insys’ fall from grace

Latest Content

Company Development Update

Novo Nordisk announced the European Commission (EC) has granted marketing authorisation for Rybelsus®, (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabetes to improve glycemic control as an adjunct to diet and exercise.

Sterivalves: Process Advantage

SteriValves was established in 1999 with the aim to supply high-quality products and services to the pharmaceutical, chemical, nuclear and food industries.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top